200 179070 advanced:7.11782625530782 case:3.24045939653538 1987:0.489454245962768 men:1.28164584264415 year:1.51122028428865 clipping:3.24045939653538 reason:3.55891312765391 cancer:4.63203032133495 case:0.975446070875874 author:7.69319040021138 part:4.02891675689965 cohort:2.32203570971108 investigators:3.37422190150464 control:2.75956739411595 design:2.29943659920322 draw:1.80971327284465 population:14.8356224663214 grow:1.60414552476454 study:1.94947521521981 eric:4.53974238066564 study:0.90215622093925 figure:1.80971327284465 men:2.38025813131226 follow:4.09293660996996 men:2.38025813131226 back:3.84659520010569 nested:4.9452074887738 gonna:3.55891312765391 entire:3.15344801954575 biological:0.60791674794131 health:4.04368568455605 study:3.80672045060016 free:1.44869992730732 questionnaire:2.27105883934727 year:0.675510039073838 started:1.66806275578162 50000:3.84659520010569 giovannucci:9.8904149775476 levels:3.22201943359773 hypothesis:1.66806275578162 lorelei:4.53974238066564 specimens:2.74798291143758 ed:0.793215308548206 1986:6.80844275158845 mucci:4.25206030821386 source:8.50412061642772 nested:8.79091340469462 nail:1.0844777777332 health:0.514390689930487 factors:0.867670044868081 professionals:10.3233902759926 prostate:11.5397856003171 study:2.38025813131226 invited:2.74798291143758 larry:1.17244655067916 interesting:0.834333624600489 hypothesis:1.38985942728439 levels:1.49521994294221 remember:0.417998844255421 researchers:3.89895043043962 rimm:4.53974238066564 risk:0.614474148487469 selenium:11.5397856003171 toenails:5.09462443195086 previous:3.69244452027843 started:1.49601108222398 published:2.99929733971849 study:5.62438793000976 biomarkers:1.71846235244443 talk:0.84683782344952 thought:3.84956520525888 thought:24.1735005413979 clark:1.54401010711165 undertook:9.07948476133128 1996:0.956223442209526 men:1.4551892245079
179070 343540 cohort:2.14184710786727 1987:14.2356525106156 talk:3.24045939653538 study:0.550758334101362 develop:0.550758334101362 cancer:10.8080707497815 cases:2.60118952233566 risk:1.14971829960161 epidemiological:3.84659520010569 authors:2.32203570971108 toenail:1.26881672677657 33000:2.4603008389858 questions:2.54731221597543 order:5.51913478823191 read:3.44113009199753 address:1.14971829960161 results:2.11199414471758 looked:2.62854220360797 researchers:2.41947884446554 compared:0.748005541111992 study:0.778542264972074 37000:3.06970245747747 compare:3.5343073168517 sampling:2.6957904563707 measure:3.15344801954575 set:3.66338435912686 results:4.9452074887738 33000:3.22201943359773 men:0.984394319176222 case:0.810040932031445 men:1.47947158597407 developing:3.44113009199753 risk:0.526366880977203 health:0.793215308548206 clark:4.53974238066564 case:2.69391569016731 number:9.53181985222383 time:8.79091340469462 identified:0.307115471686182 occurred:1.57791165878733 advanced:0.984394319176222 set:1.78820706762369 line:1.7263316639056 melanoma:1.02878137986097 cohort:2.80514132527753 nested:6.88226018399506 1994:19.2329760005284 trial:2.08144342766796 study:2.34489310135832 prostate:0.654748047625409 estimate:1.52748080516043 controls:4.68503560665884 controls:0.417998844255421 follow:3.89895043043962 specimen:1.26881672677657 cases:4.91579318789975 risk:2.67416547903098 sampling:2.89739985461464 professionals:7.69319040021138 undertook:1.50265792171544 randomized:3.69244452027843 men:5.09462443195086 professionals:3.69244452027843 select:2.36816333895148 randomized:0.42341891172476 chance:1.83169217956343 developing:0.0700101655726489 health:16.1156670275986 found:3.0880202142233 cancer:4.53974238066564 toenails:0.970126149671934
343540 506030 advanced:3.55891312765391 reflect:1.70652903660942 study:1.14971829960161 measurement:5.9243790696123 study:2.64262239577975 cancer:4.63203032133495 potential:0.650297380583916 exposure:2.59383223161032 undertaken:3.84659520010569 relates:1.26881672677657 categorize:2.59383223161032 biases:1.92478260262944 relate:2.08300660784433 case:1.49521994294221 subsequent:3.3357695763397 set:1.8397115960773 limitations:4.25206030821386 definition:1.68711095075232 diagnosed:6.67225102312648 discuss:1.9747930232041 continuous:0.725699783597694 measurement:1.43366204994278 measure:0.462204936759917 bias:0.748005541111992 1993:5.73153189418792 relates:7.76729548488036 epidemiology:2.4390281230743 recently:0.778542264972074 study:1.76715365842585 influence:3.55891312765391 risk:2.34251780332942 study:0.249282939517245 selenium:0.60791674794131 years:5.84842564565943 ago:1.52748080516043 study:4.9452074887738 window:1.07400647786591 interpretation:1.66806275578162 secondary:1.47947158597407 question:1.98303827137052 published:2.72337710063538 control:0.153557735843091 study:9.8904149775476 participant:7.69913041051776 question:0.582108863985438 risk:5.91788634389628 prostate:11.5397856003171 clark:2.38025813131226 question:4.16288685533593 divided:4.53974238066564 contrast:2.34489310135832 20:3.07340531187221 levels:2.99043988588442 concerned:2.34251780332942 1990:3.84493752793245 risk:3.07237074243734 sampling:0.668541369757745 randomized:4.02891675689965 question:15.3863808004228 set:0.75132896085772 things:2.59383223161032 measurement:1.77612250421361 question:3.07340531187221 selenium:0.209009040379305 question:4.53974238066564 equal:2.38025813131226 measurement:0.485063074835967 exposure:4.25206030821386
506030 654100 advanced:3.55891312765391 guess:2.02743675668952 agent:2.93030446823154 ago:1.70652903660942 question:0.538488241509547 association:2.23313218456942 placebo:2.1689555554664 based:1.00362568110411 explanations:1.9747930232041 biomarkers:3.55891312765391 blood:1.40424816473649 randomized:0.281768394661733 cancer:12.3520808568932 chemo:4.9452074887738 larry:3.84659520010569 logging:2.86576594709396 trial:0.634408363388287 controlled:1.9747930232041 epidemiological:2.08300660784433 conducted:2.54731221597543 plausible:1.36168855031769 years:3.3357695763397 disadvantages:1.8397115960773 final:6.88226018399506 data:0.231182897873627 factorial:1.14971829960161 time:2.64262239577975 question:2.99929733971849 evidence:0.96552583487184 epidemiological:12.0973942223277 104:1.87715455364018 concerned:2.38025813131226 bias:1.29454924748006 called:3.44113009199753 epidemiological:1.21951406153715 published:1.02323415249249 critique:2.30615015915854 found:5.30146097527755 prostate:2.64262239577975 states:2.64262239577975 institute:3.3357695763397 confounding:1.52748080516043 inverse:2.99929733971849 results:4.9452074887738 critique:3.24045939653538 levels:1.07400647786591 answers:2.34251780332942 35000:1.36168855031769 national:2.4603008389858 interpretation:0.654748047625409 questions:1.0844777777332 placebo:5.0057209068092 study:3.44113009199753 forward:2.86576594709396 potential:1.47947158597407 preventive:7.78149669483096 primary:2.38025813131226 prostate:23.0795712006341 found:3.07340531187221 post:2.05483573087764 study:2.38025813131226 cancer:2.08144342766796 randomized:5.8622327533958 design:1.87715455364018 recruited:3.07340531187221 cancer:2.34251780332942 studies:0.634408363388287 risk:2.45789659394988 select:2.89739985461464 selenium:30.7727616008455 specifically:1.29454924748006 united:1.41884696415764 study:3.25622459105828 effect:3.69244452027843 thinking:1.83169217956343 providing:1.92478260262944 cancer:0.0700101655726489 toenails:4.02891675689965 trail:4.9452074887738 trial:3.0880202142233 undertaken:9.07948476133128 undertook:4.53974238066564 men:1.70652903660942 selenium:5.99859467943698 years:0.970126149671934
